
Oral squamous cell carcinoma (OSCC) is a malignant tumor accounting for more than 90% of oral cancers and the tongue is the most common OSCC site, which accounts for about 50% or more1. The tongue, unlike other tissues in the oral cavity, has a characteristic structure including a high content of muscle bundles and a rich lymphatic chain2. A high proportion of muscles in the tongue make so that it can be a routes for tumoral spread through muscle fibers, thus local recurrence could be higher with muscle invasion3. In addition to creating a specific tumor microenvironment, it can also induce lots of shrinkage at resection which is affected by tissue composition and tumor cells cohesiveness.(Fig. 1) As reported in previous studies4, the tissue shrinkage in the tongue had been reported to 23.5%-42.14%, which showed greater shrinkage compared to other location of the oral cavity. The microenvironment of the medial side which is adjacent to the muscular tissue of the tongue, neurovascular bundle, and mesenchymal tissue makes the boundary of the tumor unclear, irregular. Also it causes spreading and invasion of tumor cells from the mass, inducing epithelial to mesenchymal transition and infiltration5. These aspects make it difficult to set the surgical margin during surgery and obtain a sufficient surgical margin, and the interaction between cancer cells and the surrounding microenvironment acts as an important factor in tumor development, invasion and metastasis5.
In addition to perineural and lympho-vascular invasion and depth of invasion, current literatures suggest that histopathologic parameters like pattern of invasion (POI) and, tumor budding should be predictors of invasion, nodal metastasis and prognostic criteria2,6-8. POI is a pathologically classified invasion pattern of the resection margin to evaluate tumor aggressiveness6-8 and to identify the worst pattern of invasion (WPOI). Tumor budding indicates loss of cellular cohesion and, active invasive movement and was defined as a single cancer cell or a cluster of less than five cancer cells in the stroma of the invasive front. According to the guideline published by the International Tumor Budding Consensus Conference, tumor budding should be assessed using ×20 objective within the hotspot at the invasive front, and graded as low (0-4 buds), intermediate (5 buds), or high (≥5 buds)7.
Because radical resection is the fundamental treatment for tongue squamous cell carcinoma (TSCC), and considering the characteristics of the tongue, it could be expected that setting the surgical margin with consideration of tumor invasion is directly related to good prognosis.
In this study, we assumed that the size of the recommended surgical margin would vary depending on margin location and the anatomical specificity of the tongue, and we analyzed TSCC prognosis, according to the value of each location of the surgical margin. Additionally, by estimate the correlation between histopathologic prognostic factor like WPOI, tumor budding, prognosis, and surgical margin, we suggest the surgical margin of TSCC should consider anatomical specificity, tumor environment of tongue, and histopathologic prognostic factors.
We reviewed 45 patients diagnosed with TSCC who visited Seoul National University Dental Hospital (SNUDH) (Seoul, Republic of Korea) from 2010 to 2019 and who were, managed by a single surgical team. This study and its access of patient records were ethically approved by the Seoul National University Institutional Review Board (S-D20170026). These patients fulfilled the following inclusion criteria: (1) complete clinical evaluation, (2) mass ablation surgery with or without radiotherapy, and exclusion criteria: (1) did not undergo surgical treatment (2) did not receive adequate follow-up.
The following clinical information of patients was retrospectively reviewed, timing of surgery, tumor stage, surgical approach, survival and local recurrence, and the adjuvant therapy after surgery. Pathologic reports were also reviewed and summarized.
The pathological features, including perineural invasion, lymphovascular invasion, and depth of invasion, which were reviewed by oral and maxillofacial pathologist, were collected.
Among 45 patients, a total of 340 diagnostic histological slides from 36 patients were scanned using an Aperio CS2 (Leica Biosystems, Nussloch, Germany) and read by Case viewer software (3DHISTECH Ltd., Budapest, Hungary). POI was classified as pushing border or finger-like border or larger separate island or small separate island or tumor satellites in all H&E-stained slides, and the worst pattern was selected as a WPOI in each patient.(Fig. 2) Tumor budding was defined as a single cell or a cluster of <5 tumor cells present in the stroma at the invasive tumor front. Slides were viewed with ×5 magnification to select the highest tumor budding area at first, and at ×20 magnification. A 0.785 mm2 standard file size was used for the budding counts.(Fig. 3) Images were graded as low (0-4 buds) and high (≥5 buds). Critical reviews with confirmed evaluation were carried out by an oral and maxillofacial pathologist.
Surgical margins were evaluated based on pathology reports and diagnostic histological slides.(Fig. 3. B, 3. C) Margin status was evaluated in 5 directions: (1) anterior; (2) posterior; (3) superior; (4) inferior; and (5) deep resection margin.
Surgical margin differences were evaluated by Student’s
A total of 45 patients were investigated, and according to the T-stage classification of the American Joint Committee on Cancer (AJCC) classification, T1 (16 patients), T2 (24 patients), T3 (2 patients), and T4 (3 patients) were included. Fifteen patients underwent transoral partial glossectomy only and 30 patients underwent neck dissection and glossectomy. Among patients who underwent neck dissection, 23 patients were also treated with free flap reconstruction. The mean invasion depth value was 0.886±0.61 cm and statistically significant difference according to T-stage was observed (
Recurrence occurred in 19 patients, among whom local recurrence occurred in 3 patients; regional recurrence occurred in 12 patients; and distant recurrence occurred in 4 patients. The mean follow-up period for the patient group was 58.60 months, the mean 3-year disease-free survival was 75.56%, and the mean 3-year LRFS was 46.67%. There was a statistically significant difference in DSS according to T-stage (
The mean surgical margins values were 0.78±0.36 cm (anterior), 0.98±0.73 cm (posterior), 0.86±0.41 cm (superior), 0.65±0.38 cm (inferior), and 0.60±0.39 cm (medial).(Supplementary Table 1) There was no significant difference except nearest margin according to T-stage and WPOI (
In the 36 patients, 2 patients were WPOI 2, 8 patients were WPOI 3, 15 patients were WPOI 4, and 11 patients were WPOI 5. Seventeen patients were classified into the low-tumor budding group, and 19 patients were classified into the high-tumor budding group.
In neck metastasis patients who were diagnosed during the first surgery with neck dissection or who later experienced recurrence at neck, 50% of patients (n=9) were WPOI 5, and just one patient had non-aggressive invasion (WPOI 1, 2, 3), which is a significant difference according to WPOI (
Regarding margin status, incidence according to WPOI and tumor budding is a shown in Table 4. In both cases, more aggressive WPOI or higher budding is significantly associated with, worse margin status (
In disease specific survival, advanced T-stage, surgical margins <0.35 cm, high tumor budding, and aggressive WPOI had high hazard ratio, but there was only significant value for advanced T-stage (T3, T4), in multivariate analysis (
The optimal surgical margin of conventional OSCC has been considered to be 5 mm9,10, but this designation is controversial11-14. However, because tongue muscle invasion impact on tumor progression and has a relatively poor TSCC prognosis, and the optimal surgical margin of TSCC is still controversial and values have been proposed, including tongue compartment surgery3,12-16. Zanoni et al.12 suggested 0.22 cm as the optimal surgical margin for the TSCC cases, where the proportion of T1 and T2 stages reached 87%. Singh et al.13 determined that a surgical margin of 0.76 cm was appropriate for TSCC in a patient group, where the proportion of early stage (T1 and T2) was about 40%. From the point of view of individual surgical margins which we expected would have different values depending on location, Lee et al.14 reported that the posterior margin and deep margin have significant differences related to survival and recurrence. In early stage (T1, T2), the cut-off value of the posterior margin was 0.45 cm and, deep margin was 0.25 cm. In advanced stage (T3, T4), the cut-off value of the posterior margin was 0.95 cm and deep margin was 0.80 cm14. In this study, in which T1, T2 stages account for 88.9% of cases, DSS, and LRFS were different at the nearest 0.35 cm margin but not significantly (
WPOI and tumor budding are known as parameters that reflect tumor invasiveness, and they especially correlate with loss of cellular cohesion, active invasive movement, and recurrence6-8. In this study, WPOI and tumor budding were evaluated as pathological parameters to evaluate the effect of invasion due to the tongue’s special muscular structure in setting the surgical margin and surgery plan. According to WPOI grade, there was a significant difference in neck metastasis (
The patient group who received adjuvant therapy showed a higher DSS than the patient group who did not receive adjuvant therapy (
Supplementary data is available at http://www.jkaoms.org.
jkaoms-48-5-249-supple.pdfThis study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2022R1F1A1069624).
S.C. wrote the manuscript. B.S.I., M.Y.E., J.Y.L., and I.J.K. participated in data collection and images. H.M. and H.J.Y. participated in the study design and helped to draft the manuscript. S.M.K. coordinated and designed the whole manuscript. All authors read and approved the final manuscript.
The current study and its access to patient records were ethically approved by the Seoul National University Institutional Review Board (S-D20170026) and are in accordance with the Helsinki declaration (2013) and its later amendments or comparable ethical standards.
No potential conflict of interest relevant to this article was reported.
Demographic details according to comparison with T-stage
Characteristic | Overall (n=45) | T1 (n=16) | T2 (n=24) | T3 (n=2) | T4 (n=3) | |
---|---|---|---|---|---|---|
Sex, male:female | 1:1.37 | 1:1.29 | 1:1.67 | 1:1.00 | 1:0.50 | 0.650 |
Mean age (yr) | 60.20 | 57.13 | 64.44 | 71.00 | 70.33 | 0.212 |
N-stage | 0.021 |
|||||
N0 | 30 (66.7) | 13 (81.3) | 16 (66.7) | 1 (50.0) | - | |
N1 | 4 (8.9) | 1 (6.3) | 3 (12.5) | - | - | |
N2 | 11 (24.4) | 2 (12.5) | 5 (20.8) | 1 (50.0) | 3 (100) | |
Surgery | ||||||
Only transoral | 15 (33.3) | 9 (56.3) | 6 (25.0) | - | - | |
With ND | 30 (66.7) | 7 (43.8) | 18 (75.0) | 2 (100) | 3 (100) | 0.032 |
With reconstruction | 23 (51.1) | 6 (37.5) | 12 (50.0) | 2 (100) | 3 (100) | 0.054 |
Mean depth of invasion (cm) | 0.886 | 0.459 | 0.875 | 1.45 | 1.733 | 0.001 |
Meta lymph node ratio | 0.10 | 0.03 | 0.21 | 0.05 | 0.24 | |
ENE | 6 (13.3) | 1 (6.3) | 3 (12.5) | 0 | 2 (66.7) | |
PNI | 9 (20.0) | 0 | 7 (29.2) | 1 (50.0) | 1 (33.3) | |
LVI | 2 (4.4) | 0 | 0 | 0 | 2 (66.7) | |
WPOI | (n=36) | (n=13) | (n=18) | (n=2) | (n=3) | 0.017 |
WPOI 2 | 2 (5.6) | 1 (7.7) | 1 (5.6) | - | - | |
WPOI 3 | 8 (22.2) | 6 (46.2) | 2 (11.1) | - | - | |
WPOI 4 | 15 (41.7) | 5 (38.5) | 7 (38.9) | 1 (50.0) | 2 (66.7) | |
WPOI 5 | 11 (30.6) | 1 (7.7) | 8 (44.4) | 1 (50.0) | 1 (33.3) | |
Tumor budding | (n=36) | (n=13) | (n=18) | (n=2) | (n=3) | 0.027 |
Low (<5 cells) | 17 (47.2) | 10 (76.9) | 5 (27.8) | 1 (50.0) | 1 (33.3) | |
High (≥5 cells) | 19 (52.8) | 3 (23.1) | 13 (72.2) | 1 (50.0) | 2 (66.7) | |
Additional Tx | 17 (37.8) | 2 (12.5) | 11 (45.8) | 1 (50.0) | 3 (100) | 0.010* |
PORT | 11 (24.4) | 2 (12.5) | 7 (29.2) | 1 (50.0) | 1 (33.3) | |
POCCRT | 3 (6.7) | - | 1 (4.2) | - | 2 (66.7) | |
Further resection | 3 (6.7) | - | 3 (12.5) | - | - | |
Recurrence | 19 (42.2) | 5 (31.3) | 11 (45.8) | 1 (50.0) | 2 (66.7) | 0.305 |
Local | 3 (6.7) | 1 (6.3) | 1 (4.2) | 1 (50.0) | - | |
Regional | 12 (26.7) | 4 (25.0) | 7 (29.2) | - | 1 (33.3) | |
Distant | 4 (8.9) | - | 3 (12.5) | - | 1 (33.3) | |
Mean follow-up period (mo) | 58.60 | 69.93 | 59.54 | 6.00 | 25.67 | 0.021 |
3-yr DSS (%) | 75.56 | 93.75 | 75.00 | 0 | 33.33 | 0.004 |
3-yr LRFS (%) | 46.67 | 62.50 | 41.67 | 0 | 33.33 | 0.201 |
(ND: neck dissection, ENE: extracapsular nodal expansion, PNI: perineural invasion, LVI: lympho-vascular invasion, WPOI: worst pattern of invasion, Tx: treatment, PORT: postoperative radiotherapy, POCCRT: postoperative concurrent chemo-radiotherapy, DSS: disease-specific survival, LRFS: loco-regional recurrence-free survival)
*
Values are presented as number only, mean only, number (%), or % only.
Pathologic evaluation with slide reading was performed in 36 patients out of a total of 45 patient groups, and WPOI and tumor budding were also evaluated in only 36 patient groups.
Comparison of surgical margin, survivor and dead group, recur-free and recur group (unit: cm)
Surgical margin | Survival | Recurrence | |||||
---|---|---|---|---|---|---|---|
Alive | Death | Recur-free | Recur | ||||
Anterior | 0.83±0.26 | 0.71±0.48 | 0.013 |
0.86±0.38 | 0.67±0.33 | 0.250 | |
Posterior | 0.96±0.75 | 1.01±0.73 | 0.59 | 0.94±0.80 | 1.03±0.66 | 0.947 | |
Superior | 0.84±0.37 | 0.89±0.48 | 0.67 | 0.90±0.49 | 0.80±0.26 | 0.057 | |
Inferior | 0.73±0.40 | 0.52±0.31 | 0.89 | 0.71±0.40 | 0.57±0.34 | 0.891 | |
Deep | 0.71±0.43 | 0.65±0.31 | 0.014 |
0.67±0.44 | 0.73±0.31 | 0.176 | |
Nearest | 0.41±0.24 | 0.37±0.24 | 0.86 | 0.40±0.26 | 0.40±0.21 | 0.128 |
*
Values are presented as mean±standard deviation.
Incidence of neck metastasis, recurrence, survival according to WPOI and tumor budding
Characteristic | WPOI | Tumor budding | ||||||
---|---|---|---|---|---|---|---|---|
WPOI 1, 2, 3 | WPOI 4 | WPOI 5 | w/o tumor budding | w/ tumor budding | ||||
Neck metastasis (n=18) | 1 (5.6) | 8 (44.4) | 9 (50.0) | 0.012 |
6 (33.3) | 12 (66.7) | 0.100 | |
Recurrence (n=17) | 2 (11.8) | 7 (41.2) | 8 (47.1) | 0.023 |
5 (29.4) | 12 (70.6) | 0.009* | |
Survival (n=26) | 10 (38.5) | 9 (34.6) | 7 (26.9) | 0.016 |
14 (53.8) | 12 (46.2) | 0.206 |
(WPOI: worst pattern of invasion, w/o: without, w/: with)
*
This
Neck metastasis includes patients with metastatic lymph node at first surgery.
Incidence of margin status according to WPOI and tumor budding
Margin status | WPOI | Tumor budding | ||||
---|---|---|---|---|---|---|
WPOI 1, 2, 3 | WPOI 4 | WPOI 5 | Low tumor budding | High tumor budding | ||
Clear margin (n=8) | 3 (37.5) | 4 (50.0) | 1 (12.5) | 5 (62.5) | 3 (37.5) | |
Closed margin (n=22) | 7 (31.8) | 10 (45.5) | 5 (22.7) | 12 (54.5) | 10 (45.5) | |
Involved margin (n=6) | - | 1 (16.7) | 5 (83.3) | - | 6 (100) |
Univariate and multivariate DSS analysis using Cox-proportional hazards model
Variable | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | ||||
T-stage | |||||||
T1 | 1 (reference) | 1 (reference) | |||||
T2 | 0.40 | 0.01-1.61 | 0.20 | 0.61 | 0.23-1.62 | 0.32 | |
T3, T4 | 1.38 | 0.16-11.79 | 0.77 | 5.11 | 1.35-19.26 | 0.016 |
|
Nearest margin | |||||||
≤0.35 | 1 (reference) | 1 (reference) | |||||
>0.35 | 3.81 | 0.55-26.58 | 0.18 | 2.80 | 0.51-15.36 | 0.24 | |
Tumor budding | |||||||
<5 | 1 (reference) | 1 (reference) | |||||
≥5 | 3.86 | 0.37-40.66 | 0.26 | 1.18 | 0.43-3.26 | 0.75 | |
WPOI | |||||||
WPOI 1, 2, 3 | 1 (reference) | ||||||
WPOI 4, 5 | 2.00 | 0.30-13.17 | 0.47 | 1.67 | 0.20-18.35 | 0.68 |
(DSS: disease specific survival, HR: hazard ratio, CI: confidence interval, WPOI: worst pattern of invasion)
*
Univariate and multivariate LRFS analysis using Cox-proportional hazards model
Variable | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | ||||
T-stage | |||||||
T1 | 1 (reference) | 1 (reference) | |||||
T2 | 0.32 | 0.25-3.82 | 0.36 | 0.67 | 0.23-1.91 | 0.45 | |
T3, T4 | 18.66 | 1.23-286.20 | 0.035 |
4.90 | 1.47-16.26 | 0.09 | |
Nearest margin | |||||||
≤0.35 | 1 (reference) | 1 (reference) | |||||
>0.35 | 2.15 | 0.30-15.55 | 0.45 | 1.24 | 0.51-3.01 | 0.63 | |
Tumor budding | |||||||
<5 | 1 (reference) | 1 (reference) | |||||
≥5 | 1.65 | 0.28-9.86 | 0.58 | 2.06 | 0.41-10.47 | 0.38 | |
WPOI | |||||||
WPOI 1, 2, 3 | 1 (reference) | ||||||
WPOI 4, 5 | 0.82 | 0.38-1.79 | 0.62 | 0.91 | 0.48-1.73 | 0.78 |
(LRFS: loco-regional recurrence-free survival, HR: hazard ratio, CI: confidence interval, WPOI: worst pattern of invasion)
*